Citations (70)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Abigail K. Winiker, Omeid Heidari, Sarah Pollock, Shereen Sodder & Karin E. Tobin. (2023) Barriers to Assessing and Treating Trauma in Primary Care and Opportunities for Improvement: Perspectives from Prescribers of Medications for Opioid Use Disorder. Substance Use & Misuse 0:0, pages 1-9.
Read now
Read now
Yatan Pal Singh Balhara, Nestor Szerman, Swarndeep Singh, Jose Martinez Raga, Caroline Salom, Lola Peris & Ragul Ganesh. (2021) Treatment Needs and Service Delivery for Patients with Dual Disorders During the COVID-19 Pandemic: Findings From the WADD Survey. Journal of Dual Diagnosis 17:3, pages 248-256.
Read now
Read now
Mackenzie Daly & Lisa M. Gargano. (2021) Factors Associated with Substance Use Disorder Treatment Completion, Rhode Island, USA, 2018. Substance Use & Misuse 56:6, pages 793-800.
Read now
Read now
Margarita Villagrana & Sei-Young Lee. (2020) Racial/Ethnic Disparities in Treatment Completion for Youths with and without a Psychiatric Comorbidity. Journal of Child & Adolescent Substance Abuse 29:2, pages 105-118.
Read now
Read now
Phillip L. Marotta, Kristi L. Stringer, Amar D. Mandavia, Alissa Davis, Leo Beletsky, Tim Hunt, Dawn Goddard-Eckrich, Elwin Wu, Louisa Gilbert & Nabila El-Bassel. (2020) Assessing factors associated with discharge from opioid agonist therapy due to incarceration in the United States. Journal of Addictive Diseases 38:1, pages 1-18.
Read now
Read now
Grace J. Đào, Caroline Brunelle & David Speed. (2019) Impact of Substance Use and Mental Health Comorbidity on Health Care Access in Canada. Journal of Dual Diagnosis 15:4, pages 260-269.
Read now
Read now
Sarvenaz Esmaeelzadeh, John Moraros, Lilian Thorpe & Yelena Bird. (2018) The association between depression, anxiety and substance use among Canadian post-secondary students. Neuropsychiatric Disease and Treatment 14, pages 3241-3251.
Read now
Read now
Maurice Dematteis, Marc Auriacombe, Oscar D’Agnone, Lorenzo Somaini, Néstor Szerman, Richard Littlewood, Farrukh Alam, Hannu Alho, Amine Benyamina, Julio Bobes, Jean Pierre Daulouede, Claudio Leonardi, Icro Maremmani, Marta Torrens, Stephan Walcher & Michael Soyka. (2017) Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus. Expert Opinion on Pharmacotherapy 18:18, pages 1987-1999.
Read now
Read now
Manuel Sutter$suffix/text()$suffix/text(), Marc Walter, Kenneth M. Dürsteler, Johannes Strasser & Marc Vogel. (2017) Psychosis After Switch in Opioid Maintenance Agonist and Risperidone-Induced Pisa Syndrome: Two Critical Incidents in Dual Diagnosis Treatment. Journal of Dual Diagnosis 13:2, pages 157-165.
Read now
Read now
Carlos Roncero, Néstor Szerman, Antonio Terán, Carlos Pino, José María Vázquez, Elena Velasco, Marta García-Dorado & Miguel Casas. (2016) Professionals’ perception on the management of patients with dual disorders. Patient Preference and Adherence 10, pages 1855-1868.
Read now
Read now
Kjeld Andersen & Bent Nielsen. (2016) Coercion in psychiatry: the importance of extramural factors. Nordic Journal of Psychiatry 70:8, pages 606-610.
Read now
Read now
Thomas M. Kelly, Dennis C. Daley & Antoine B. Douaihy. (2014) Contingency Management for Patients With Dual Disorders in Intensive Outpatient Treatment for Addiction. Journal of Dual Diagnosis 10:3, pages 108-117.
Read now
Read now
Articles from other publishers (58)
Kaisa E. Luoto, Antero Lassila, Esa Leinonen & Olli Kampman. (2023) Predictors of short-term response and the role of heavy alcohol use in treatment of depression. BMC Psychiatry 23:1.
Crossref
Crossref
Thiago Henrique Roza, Lucas Tavares Noronha, Augusto Ossamu Shintani, Raffael Massuda, Maria Inês Rodrigues Lobato, Felix Henrique Paim Kessler & Ives Cavalcante Passos. (2023) Treatment Approaches for Problematic Pornography Use: A Systematic Review. Archives of Sexual Behavior.
Crossref
Crossref
Silvia Díaz Fernández, Juan José Fernandez Miranda, Francisco Pascual Pastor & Francisco López Muñoz. (2023) Gender and addiction and other mental disorders comorbidity: sociodemographic, clinical, and treatment differences. Archives of Women's Mental Health 26:5, pages 639-650.
Crossref
Crossref
Jill A. Rabinowitz, Jennifer D. Ellis, Jonathan Wells, Justin C. Strickland, Brion S. Maher, Joseph G. Hobelmann & Andrew Huhn. (2023) Correlates and consequences of anxiety and depressive symptom trajectories during early treatment for alcohol use. Alcohol 108, pages 44-54.
Crossref
Crossref
Elizabeth McCord, Charlotte Van Hale & Yi-Lang Tang. 2023. Substance Use and Addiction Research. Substance Use and Addiction Research
349
367
.
Juan José Fernández-Miranda, Francisco Pascual-Pastor, Silvia Díaz-Fernández, Daniela Navarro & Jorge Manzanares. (2022) Differences in Substance Use Disorders and Other Mental Disorders in Mental Health and Addiction Settings: Sociodemographic, Clinical, Drug Treatment, and Gender Differences. International Journal of Mental Health and Addiction.
Crossref
Crossref
M. Ruth Lavergne, Jackson P. Loyal, Mehdi Shirmaleki, Ridhwana Kaoser, Tonia Nicholls, Christian G. Schütz, Adam Vaughan, Hasina Samji, Joseph H. Puyat, Megan Kaulius, Wayne Jones & William Small. (2022) The relationship between outpatient service use and emergency department visits among people treated for mental and substance use disorders: analysis of population-based administrative data in British Columbia, Canada. BMC Health Services Research 22:1.
Crossref
Crossref
Ahmed A. Moustafa, Richard Tindle, Sharon Cashel, Denise Parkes, Enas Mohamed & Eid Abo Hamza. (2020) Bidirectional relationship between heroin addiction and depression: Behavioural and neural studies. Current Psychology 41:8, pages 5195-5211.
Crossref
Crossref
Marion Selfridge, Kiffer Card, Taylor Kandler, Erin Flanagan, Emily Lerhe, Ash Heaslip, Anne Nguyen, Matthew Moher, Bernie Pauly, Karen Urbanoski & Chris Fraser. (2022) Factors associated with 60-day adherence to “safer supply” opioids prescribed under British Columbia's interim clinical guidance for health care providers to support people who use drugs during COVID-19 and the ongoing overdose emergency. International Journal of Drug Policy 105, pages 103709.
Crossref
Crossref
Eve K. Chesivoir, Stephanie Valle & Jon E. Grant. (2022) Comorbid trichotillomania and attention-deficit hyperactivity disorder in adults. Comprehensive Psychiatry 116, pages 152317.
Crossref
Crossref
Michiel W. van Kernebeek, Florence Vorspan, Cleo L. Crunelle, Wim van den Brink, Geert Dom, Franz Moggi, Maija Konstenius, Johan Franck, Frances R. Levin, Geurt van de Glind, Jose A. Ramos-Quiroga, Zsolt Demetrovics, Corné Coetzee, Mathias Luderer, Arnt Schellekens, Frieda Matthys & Romain Icick. (2022) Consensus International sur le dépistage, le diagnostic et le traitement des patients avec troubles de l’usage de substances en cas de comorbidité avec un trouble du déficit de l’attention avec ou sans hyperactivité. Toxicologie Analytique et Clinique 34:2, pages 55-67.
Crossref
Crossref
Edith López-Toro, Casper J. H. Wolf, Rafael A. González, Wim van den Brink, Arnt Schellekens & María C. Vélez-Pastrana. (2022) Network Analysis of DSM Symptoms of Substance Use Disorders and Frequently Co-Occurring Mental Disorders in Patients with Substance Use Disorder Who Seek Treatment. Journal of Clinical Medicine 11:10, pages 2883.
Crossref
Crossref
Carlos Alva-Diaz, Andrely Huerta-Rosario, Roberto A. Molina, Kevin Pacheco-Barrios, Wilfor Aguirre-Quispe, Alba Navarro-Flores, Victor Velásquez-Rimachi, Hernan Alexander Sinche-Espinal, Juan Carlos Ocampo-Zegarra, Luis Armando Andamayo-Villalba, Tatiana Metcalf, Marcela Chahua & Roberto Romero Sanchez. (2020) Mental and substance use disorders in Peru: a systematic analysis of the Global Burden of Disease study. Journal of Public Health 30:3, pages 629-638.
Crossref
Crossref
Maria A. Sullivan. 2022. Substance and Non-Substance Related Addictions. Substance and Non-Substance Related Addictions
3
17
.
Dean Rivera, Donna Dueker & Hortensia Amaro. (2021) Examination of referral source and retention among women in residential substance use disorder treatment: a prospective follow-up study. Substance Abuse Treatment, Prevention, and Policy 16:1.
Crossref
Crossref
Amanda Blair SpenceKatherine MichelCuiwei WangMary Ann DuttonKathryn LeeDaniel MerensteinLucile Adams-CampbellKatheryn BellAnjali KikkisettiAllison DoyleMikayla CochraneLakshmi GoparajuSeble Kassaye. (2021) Viral Suppression Is Associated with HIV Treatment Self-Efficacy in a Cohort of Women in Washington, DC. AIDS Patient Care and STDs 35:3, pages 75-83.
Crossref
Crossref
Sunsha Chamakalayil, Johannes Strasser, Marc Vogel, Serge Brand, Marc Walter & Kenneth M. Dürsteler. (2021) Methylphenidate for Attention-Deficit and Hyperactivity Disorder in Adult Patients With Substance Use Disorders: Good Clinical Practice. Frontiers in Psychiatry 11.
Crossref
Crossref
Jørn Henrik Vold, Christer Aas, Svetlana Skurtveit, Ingvild Odsbu, Fatemeh Chalabianloo, Anne Halmøy, Kjell Arne Johansson & Lars Thore Fadnes. (2020) Dispensation of attention deficit hyperactivity disorder (ADHD) medications in patients receiving opioid agonist therapy; a national prospective cohort study in Norway from 2015 to 2017. BMC Psychiatry 20:1.
Crossref
Crossref
Erik Loewen Friesen & Paul Kurdyak. (2020) The impact of psychiatric comorbidity on treatment discontinuation among individuals receiving medications for opioid use disorder. Drug and Alcohol Dependence 216, pages 108244.
Crossref
Crossref
Paul Brunault, Kevin Lebigre, Fatima Idbrik, Damien Maugé, Philippe Adam, Servane Barrault, Grégoire Baudin, Robert Courtois, Hussein El Ayoubi, Marie Grall-Bronnec, Coraline Hingray, Nicolas Ballon & Wissam El-Hage. (2020) Childhood Trauma Predicts Less Remission from PTSD among Patients with Co-Occurring Alcohol Use Disorder and PTSD. Journal of Clinical Medicine 9:7, pages 2054.
Crossref
Crossref
Claudia Fantuzzi & Roberto Mezzina. (2020) Dual diagnosis: A systematic review of the organization of community health services. International Journal of Social Psychiatry 66:3, pages 300-310.
Crossref
Crossref
Samantha Colledge, Sarah Larney, Amy Peacock, Janni Leung, Matt Hickman, Jason Grebely, Michael Farrell & Louisa Degenhardt. (2020) Depression, post-traumatic stress disorder, suicidality and self-harm among people who inject drugs: A systematic review and meta-analysis. Drug and Alcohol Dependence 207, pages 107793.
Crossref
Crossref
Stefano Pallanti & Luana SalernoStefano Pallanti & Luana Salerno. 2020. The Burden of Adult ADHD in Comorbid Psychiatric and Neurological Disorders. The Burden of Adult ADHD in Comorbid Psychiatric and Neurological Disorders
307
345
.
Stefano Pallanti & Luana SalernoStefano Pallanti & Luana Salerno. 2020. The Burden of Adult ADHD in Comorbid Psychiatric and Neurological Disorders. The Burden of Adult ADHD in Comorbid Psychiatric and Neurological Disorders
253
269
.
Bushra Sabri, Claire Greene & Gregory M. Lucas. (2019) A systematic review of comprehensive interventions for substance abuse: Focus on victimization. Aggression and Violent Behavior 48, pages 46-59.
Crossref
Crossref
Priscilla Novak, Kenneth A. Feder, Mir M. Ali & Jie Chen. (2019) Behavioral health treatment utilization among individuals with co-occurring opioid use disorder and mental illness: Evidence from a national survey. Journal of Substance Abuse Treatment 98, pages 47-52.
Crossref
Crossref
Mary Wiktorowicz, Aber Abdulle, Kaitlin Di Pierdomenico & Sheila A. Boamah. (2019) Models of Concurrent Disorder Service: Policy, Coordination, and Access to Care. Frontiers in Psychiatry 10.
Crossref
Crossref
Kenneth M. Dürsteler, Marc Vogel & Marc Walter. 2019. Suchtmedizin. Suchtmedizin
67
79
.
Joseph SadekJoseph Sadek. 2019. Clinician’s Guide to ADHD Comorbidities in Children and Adolescents. Clinician’s Guide to ADHD Comorbidities in Children and Adolescents
61
75
.
David H. Morris, Alan K. Davis, Kirstin J. Lauritsen, C. Martin Rieth, Mark M. Silvestri, Jamie J. Winters & Stephen T. Chermack. (2018) Substance use consequences, mental health problems, and readiness to change among Veterans seeking substance use treatment. Journal of Substance Abuse Treatment 94, pages 113-121.
Crossref
Crossref
Judit Tirado-Muñoz, Gail Gilchrist, Gabriele Fischer, Avril Taylor, Jacek Moskalewicz, Cinzia Giammarchi, Birgit Köchl, Alison Munro, Katarzyna Dąbrowska, April Shaw, Lucia Di Furia, Isabella Leeb, Caroline Hopf & Marta Torrens. (2017) Psychiatric comorbidity and intimate partner violence among women who inject drugs in Europe: a cross-sectional study. Archives of Women's Mental Health 21:3, pages 259-269.
Crossref
Crossref
Ayman M. Hamdan-Mansour, Ahmad Y. Al-Sagarat, Faris AL-Sarayreh, Hani Nawafleh & Diana H. Arabiat. (2018) Prevalence and correlates of substance use among psychiatric inpatients. Perspectives in Psychiatric Care 54:2, pages 149-155.
Crossref
Crossref
Suhas Ganesh, Arun Kandasamy, UbaharaS Sahayaraj & Vivek Benegal. (2018) Behavioral activation and behavioral inhibition sensitivities in patients with substance use disorders: A study from India. Indian Journal of Psychiatry 60:3, pages 346.
Crossref
Crossref
Cleo L. Crunelle, Wim van den Brink, Franz Moggi, Maija Konstenius, Johan Franck, Frances R. Levin, Geurt van de Glind, Zsolt Demetrovics, Corné Coetzee, Mathias Luderer, Arnt Schellekens & Frieda Matthys. (2018) International Consensus Statement on Screening, Diagnosis and Treatment of Substance Use Disorder Patients with Comorbid Attention Deficit/Hyperactivity Disorder. European Addiction Research 24:1, pages 43-51.
Crossref
Crossref
Benjamin Keller, Joan-Ignasi Mestre-Pinto, María Álvaro-Bartolomé, Diana Martinez-Sanvisens, Magí Farre, M. Julia García-Fuster, Jesús A. García-Sevilla & Marta Torrens. (2017) A Biomarker to Differentiate between Primary and Cocaine-Induced Major Depression in Cocaine Use Disorder: The Role of Platelet IRAS/Nischarin (I1-Imidazoline Receptor). Frontiers in Psychiatry 8.
Crossref
Crossref
Fernanda de Sousa Vieira, Massimiliano Minelli & Clarissa Mendonça Corradi-Webster. (2017) Consumo de drogas por pessoas com diagnósticos psiquiátricos: percursos possíveis em uma rede de atenção psicossocial. Physis: Revista de Saúde Coletiva 27:4, pages 1243-1263.
Crossref
Crossref
Hélène PeyrièreCaroline DiotErika NogueMarie VerschaveMorgan LaureMarie-Christine PicotPierre PetitHélène Donnadieu-RigoleYves Leglise. (2017) Prevalence of Antipsychotic-Treated Patients in a Cohort of Adult Addicted Patients. Journal of Clinical Psychopharmacology 37:6, pages 669-674.
Crossref
Crossref
Rosa Maza-Quiroga, Nuria García-Marchena, Pablo Romero-Sanchiz, Vicente Barrios, María Pedraz, Antonia Serrano, Raquel Nogueira-Arjona, Juan Jesus Ruiz, Maribel Soria, Rafael Campos, Julie Ann Chowen, Jesus Argente, Marta Torrens, Meritxell López-Gallardo, Eva María Marco, Fernando Rodríguez de Fonseca, Francisco Javier Pavón & Pedro Araos. (2017) Evaluation of plasma cytokines in patients with cocaine use disorders in abstinence identifies transforming growth factor alpha (TGFα) as a potential biomarker of consumption and dual diagnosis. PeerJ 5, pages e3926.
Crossref
Crossref
Noa Krawczyk, Kenneth A. Feder, Brendan Saloner, Rosa M. Crum, Marc Kealhofer & Ramin Mojtabai. (2017) The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a U.S. national sample. Drug and Alcohol Dependence 175, pages 157-163.
Crossref
Crossref
Gail Gilchrist, Polly Radcliffe, Ana Regina Noto & Ana Flávia Pires Lucas d'Oliveira. (2016) The prevalence and factors associated with ever perpetrating intimate partner violence by men receiving substance use treatment in Brazil and England: A cross‐cultural comparison. Drug and Alcohol Review 36:1, pages 34-51.
Crossref
Crossref
Laurence Lalanne, Luisa Weiner & Gilles Bertschy. 2017. Handbook of Treatments for Autism Spectrum Disorder. Handbook of Treatments for Autism Spectrum Disorder
377
395
.
Joseph SadekJoseph Sadek. 2017. Clinician’s Guide to Adult ADHD Comorbidities. Clinician’s Guide to Adult ADHD Comorbidities
41
53
.
Ana Adan & Irina Benaiges. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse
258
268
.
Gail Gilchrist, Polly Radcliffe, Mary McMurran & Liz Gilchrist. (2015) The need for evidence‐based responses to address intimate partner violence perpetration among male substance misusers. Criminal Behaviour and Mental Health 25:4, pages 233-238.
Crossref
Crossref
Harry Man Xiong Lai, Michelle Cleary, Thiagarajan Sitharthan & Glenn E. Hunt. (2015) Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: A systematic review and meta-analysis. Drug and Alcohol Dependence 154, pages 1-13.
Crossref
Crossref
Jaime Delgadillo, Stuart Gore, Shehzad Ali, David Ekers, Simon Gilbody, Gail Gilchrist, Dean McMillan & Elizabeth Hughes. (2015) Feasibility Randomized Controlled Trial of Cognitive and Behavioral Interventions for Depression Symptoms in Patients Accessing Drug and Alcohol Treatment. Journal of Substance Abuse Treatment 55, pages 6-14.
Crossref
Crossref
Marta Torrens & Paola Rossi. 2015. Co-occurring Addictive and Psychiatric Disorders. Co-occurring Addictive and Psychiatric Disorders
103
117
.
Carlos Roncero, Pablo Vega, Jose Martínez-Raga, Carmen Barral, Ignacio Basurte-Villamor, Laia Rodríguez-Cintas, Beatriz Mesías, Lara Grau-López, Miguel Casas & Nestor Szerman. (2014) Professionals’ perceptions about healthcare resources for co-occuring disorders in Spain. International Journal of Mental Health Systems 8:1.
Crossref
Crossref
Rolf-Dieter Stieglitz & Maria Hofecker Fallahpour. (2014) Psycho- und Pharmakotherapie bei ADHS und Substanzmissbrauch. DNP - Der Neurologe und Psychiater 15:12, pages 47-56.
Crossref
Crossref
Patrícia Varela, João Carlos Escosteguy-Neto, Carolina Tesone Coelho, Luiz Eugênio Mello, Dartiu Xavier da Silveira & Jair Guilherme Santos-Junior. (2014) Chronic light deprivation inhibits appetitive associative learning induced by ethanol and its respective c-Fos and pCREB expression. The International Journal of Neuropsychopharmacology 17:11, pages 1815-1830.
Crossref
Crossref
Rahul (Tony) Rao. 2014. Substance Use and Older People. Substance Use and Older People
340
350
.
Jean-Pierre Daulouède & Cecilia Maitre. 2014. Addictions et comorbidités. Addictions et comorbidités
401
411
.
Dominique Morisano, Thomas F. Babor & Katherine A. Robaina. (2017) Co-Occurrence of Substance use Disorders with other Psychiatric Disorders: Implications for Treatment Services. Nordic Studies on Alcohol and Drugs 31:1, pages 5-25.
Crossref
Crossref
Anne-Marit Langås. (2014) Komorbide lidelser ved rusmiddelavhengighet må behandles. Tidsskrift for Den norske legeforening 134:9, pages 918-918.
Crossref
Crossref
Joan Ignasi Mestre-Pintó, Antònia Domingo-Salvany, Rocío Martín-Santos & Marta Torrens. (2014) Dual Diagnosis Screening Interview to Identify Psychiatric Comorbidity in Substance Users: Development and Validation of a Brief Instrument. European Addiction Research 20:1, pages 41-48.
Crossref
Crossref
Marcela Chahua, Luis Sordo, Gregorio Barrio, Antonia Domingo-Salvany, M.Teresa Brugal, Gemma Molist, Luis de la Fuente & María J. Bravo. (2014) Non-Fatal Opioid Overdose and Major Depression among Street-Recruited Young Heroin Users. European Addiction Research 20:1, pages 1-7.
Crossref
Crossref
A. Yacobi, E. Fruchter, J.J. Mann & L. Shelef. (2013) Differentiating army suicide attempters from psychologically treated and untreated soldiers: A demographic, psychological and stress-reaction characterization. Journal of Affective Disorders 150:2, pages 300-305.
Crossref
Crossref
Birgit Koechl, Simon M Danner, Reinhold Jagsch, Laura Brandt & Gabriele Fischer. (2014) Health-related and legal interventions: A comparison of allegedly delinquent and convicted opioid addicts in Austria. Drug Science, Policy and Law 1, pages 205032451452844.
Crossref
Crossref